AdvisorShares Psychedelics ETF—— (—)Compass Pathways—— (—)Definium Therapeutics—— (—)GH Research—— (—)Helus Pharma—— (—)MIRA Pharmaceuticals—— (—)Neuphoria Therapeutics—— (—)Eli Lilly—— (—)Johnson & Johnson—— (—)AbbVie—— (—)Otsuka Pharmaceutical—— (—)Numinus Wellness—— (—)Optimi Health—— (—)PharmAla Biotech—— (—)Enveric Biosciences—— (—)Incannex Healthcare—— (—)Aurora Cannabis—— (—)Cronos Group—— (—)SNDL—— (—)Bright Minds Biosciences—— (—)PharmaTher Holdings—— (—)IM Cannabis—— (—)MariMed—— (—)Vireo Growth—— (—)

Loading prices

Techtimes

Published November 10, 2026 · Updated November 11, 2026

PharmAla Biotech Signs MDMA Supply and Data Deal With Danish Hospital for Veterans PTSD Trial

Read the full story at Techtimes

The agreement is not just a drug sale. It is a data license, and the terms reveal as much about how psychedelic medicine is trying to solve its.

Post on X

Share this story

Surfaced by this Google Alert

Psychedelic biotech